tiprankstipranks
Trending News
More News >
Boston Scientific (BSX)
NYSE:BSX
US Market

Boston Scientific (BSX) Ratios

Compare
4,150 Followers

Boston Scientific Ratios

BSX's free cash flow for Q4 2025 was $0.74. For the 2025 fiscal year, BSX's free cash flow was decreased by $ and operating cash flow was $0.18. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.62 1.62 1.08 1.32 1.51
Quick Ratio
1.08 1.08 0.64 0.82 1.02
Cash Ratio
0.38 0.38 0.06 0.18 0.24
Solvency Ratio
0.20 0.15 0.18 0.18 0.12
Operating Cash Flow Ratio
0.83 0.83 0.54 0.51 0.40
Short-Term Operating Cash Flow Coverage
11.66 11.66 1.93 4.71 76.30
Net Current Asset Value
$ -10.41B$ -10.41B$ -10.47B$ -9.09B$ -9.14B
Leverage Ratios
Debt-to-Assets Ratio
0.28 0.28 0.28 0.27 0.29
Debt-to-Equity Ratio
0.51 0.51 0.51 0.49 0.53
Debt-to-Capital Ratio
0.34 0.34 0.34 0.33 0.35
Long-Term Debt-to-Capital Ratio
0.32 0.32 0.29 0.31 0.34
Financial Leverage Ratio
1.80 1.80 1.81 1.82 1.85
Debt Service Coverage Ratio
5.94 4.39 1.62 3.81 4.75
Interest Coverage Ratio
11.22 11.38 6.81 8.02 3.93
Debt to Market Cap
0.11 0.08 0.08 0.11 0.13
Interest Debt Per Share
8.61 8.62 7.84 6.72 6.81
Net Debt to EBITDA
2.11 2.78 2.73 2.50 3.05
Profitability Margins
Gross Profit Margin
69.01%69.01%61.31%62.02%60.83%
EBIT Margin
19.46%18.60%15.94%15.85%12.66%
EBITDA Margin
24.45%18.60%23.51%24.25%21.61%
Operating Profit Margin
19.78%19.78%15.73%15.32%14.38%
Pretax Profit Margin
16.86%16.86%13.63%13.94%9.00%
Net Profit Margin
14.40%14.38%11.07%11.19%5.50%
Continuous Operations Profit Margin
14.41%14.41%11.02%11.18%5.50%
Net Income Per EBT
85.38%85.26%81.24%80.25%61.17%
EBT Per EBIT
85.24%85.24%86.60%91.01%62.55%
Return on Assets (ROA)
6.62%6.61%4.71%4.53%2.15%
Return on Equity (ROE)
12.53%11.91%8.52%8.26%3.97%
Return on Capital Employed (ROCE)
10.39%10.39%7.99%7.22%6.36%
Return on Invested Capital (ROIC)
8.78%8.78%6.13%5.69%3.89%
Return on Tangible Assets
15.73%15.71%11.87%10.80%5.11%
Earnings Yield
2.79%2.04%1.41%1.90%1.05%
Efficiency Ratios
Receivables Turnover
6.86 6.86 6.55 6.39 6.44
Payables Turnover
5.44 5.44 6.75 5.74 5.76
Inventory Turnover
2.11 2.11 2.31 2.18 2.66
Fixed Asset Turnover
4.46 4.46 4.47 4.32 4.48
Asset Turnover
0.46 0.46 0.43 0.41 0.39
Working Capital Turnover Ratio
6.62 10.36 15.93 8.05 6.34
Cash Conversion Cycle
158.81 158.81 159.96 161.16 130.54
Days of Sales Outstanding
53.20 53.20 55.75 57.11 56.70
Days of Inventory Outstanding
172.73 172.73 158.28 167.62 137.17
Days of Payables Outstanding
67.12 67.12 54.07 63.57 63.33
Operating Cycle
225.93 225.93 214.03 224.73 193.87
Cash Flow Ratios
Operating Cash Flow Per Share
3.06 3.06 2.33 1.72 1.07
Free Cash Flow Per Share
2.44 2.47 1.80 1.17 0.64
CapEx Per Share
0.61 0.59 0.54 0.55 0.43
Free Cash Flow to Operating Cash Flow
0.80 0.81 0.77 0.68 0.60
Dividend Paid and CapEx Coverage Ratio
4.99 5.18 4.35 3.02 2.29
Capital Expenditure Coverage Ratio
4.99 5.18 4.35 3.13 2.49
Operating Cash Flow Coverage Ratio
0.37 0.37 0.31 0.26 0.16
Operating Cash Flow to Sales Ratio
0.23 0.23 0.21 0.18 0.12
Free Cash Flow Yield
3.50%2.59%2.01%2.03%1.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
35.81 48.91 70.89 52.73 94.83
Price-to-Sales (P/S) Ratio
5.16 7.03 7.85 5.90 5.22
Price-to-Book (P/B) Ratio
4.27 5.82 6.04 4.36 3.77
Price-to-Free Cash Flow (P/FCF) Ratio
28.57 38.59 49.69 49.32 72.42
Price-to-Operating Cash Flow Ratio
22.82 31.13 38.26 33.56 43.37
Price-to-Earnings Growth (PEG) Ratio
9.67 0.88 4.27 0.37 -2.69
Price-to-Fair Value
4.27 5.82 6.04 4.36 3.77
Enterprise Value Multiple
23.21 40.59 36.10 26.82 27.20
Enterprise Value
113.93B 151.53B 142.17B 92.62B 74.54B
EV to EBITDA
23.21 40.59 36.10 26.82 27.20
EV to Sales
5.68 7.55 8.49 6.50 5.88
EV to Free Cash Flow
31.43 41.42 53.75 54.39 81.56
EV to Operating Cash Flow
25.13 33.42 41.39 37.01 48.85
Tangible Book Value Per Share
-0.56 -0.56 -1.20 -0.59 -0.87
Shareholders’ Equity Per Share
16.34 16.37 14.79 13.27 12.29
Tax and Other Ratios
Effective Tax Rate
0.15 0.15 0.19 0.20 0.39
Revenue Per Share
13.54 13.56 11.38 9.80 8.87
Net Income Per Share
1.95 1.95 1.26 1.10 0.49
Tax Burden
0.85 0.85 0.81 0.80 0.61
Interest Burden
0.87 0.91 0.86 0.88 0.71
Research & Development to Revenue
0.10 0.10 0.10 0.10 0.10
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.01 0.01 0.02 0.02 0.02
Income Quality
1.57 1.57 1.86 1.57 2.19
Currency in USD